Patients unable to control their cholesterol levels with medications may someday be able to lower their "bad" cholesterol with a shot, according to research presented at the American Heart Association ...

Big news for those concerned about their heart health: Pharmaceutical company Merck has created a new pill called enlicitide, which promises to lower "bad" cholesterol as effectively as injectable ...

While currently available PCSK9 inhibitor medications to lower cholesterol must be administered every few weeks by injection, a new, investigational PCSK9 inhibitor called recaticimab safely lowered ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

A cholesterol-busting jab that is administered twice a year has the potential to transform heart care, according to its developer. It comes as new trial data suggests Leqvio, also known as inclisiran ...

Scientists report that a new DNA-based treatment lowered bad cholesterol by nearly 50% after one injection targeting the ...

Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with FDA approval for subcutaneous use. The LIBerate Program showed sustained ...

TARRYTOWN, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) announced the U.S. Food & Drug Administration (FDA) has extended the approval of Praluent ® (alirocumab) as ...

Researchers used tiny DNA-based molecules to cut levels of LDL (bad) cholesterol by nearly 50% in animal models. This was done without the side effects that are often linked to statins.